MUDr. Markéta Bednaříková, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 8280, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 65
2023
-
Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Year: 2023, type: Conference abstract
-
Molekulární testování karcinomu endometria - analýza prvních zkušeností z klinické praxe
Klinická onkologie, year: 2023, volume: 36, edition: 3, DOI
-
Novinky v systémové léčbě karcinomu endometria
Year: 2023, type: Article in Periodical (without peer review)
-
Příznivý účinek multimodálního léčebného přístupu u pacientky s primárně pokročilým karcinomem endometria – kazuistika
Year: 2023, type: Article in Periodical (without peer review)
-
THE COMBINED GENOMIC AND IMMUNOHISTOCHEMICAL TUMOR PROFILING AS A TOOL OF PRECISION ONCOLOGY APPROACH IN THE REAL-WORLD COHORT OF PATIENTS WITH GYNECOLOGICAL CANCERS
Year: 2023, type: Conference abstract
-
The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series.
Year: 2023, type: Conference abstract
-
Význam nového prediktivního markeru Schlafen 11 u pacientek s karcinomem ovaria léčených chemoterapií založené na platinovém derivátu – výsledky pilotní analýzy
Klinická onkologie, year: 2023, volume: 36, edition: Suppl 1, DOI
2022
-
2022-RA-1304-ESGO Molecular testing of endometrial carcinoma brings growing opportunity to identify patients with inherited risk of cancer
Year: 2022, type: Conference abstract
-
Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
Cancers, year: 2022, volume: 14, edition: 10, DOI
-
Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
Cancers, year: 2022, volume: 14, edition: 1, DOI